[Lecture Report] The 12th NIKKEI FT Communicable Diseases Conference -What new values are required in an age of division?- (Nikkei Inc., October 7-8, 2025, Osaka City, Osaka)
date : 11/19/2025
Tags: AMR
On October 7-8, 2025, Health and Global Policy Institute (HGPI) Chair Mr. Ryoji Noritake and Manager Ms. Yui Kohno spoke at various programs throughout each day of The 12th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-organizer by THE FINANCIAL TIMES LTD.
For details, please visit the event website, which can be found here.

Below is an excerpt from the program.
October 7 (Tue)
Special Session2 Reimagine Drug Discovery Ecosystem for Infectious Diseases Prevention: Challenges and Policy Outlook
Moderator: Ryoji Noritake (Chair, HGPI)
Special Session3 Initiatives to Secure Medical Countermeasures (MCM)
Moderator: Yui Kohno (Manager, HGPI)
Special Session4 Enhancing Drug Discovery Research Activities as a Key Measure Against AMR: The Importance of Incentives and Actions for Global Synergy
Moderator: Ryoji Noritake (Chair, HGPI)
Agenda2 – Summary
Discussers:
Ryoji Noritake (Chair, HGPI)
Yui Kohno (Manager, HGPI)
October 8 (Wed)
Conclusion/Statement
Discusser: Ryoji Noritake (Chair, HGPI)
![]() |
![]() |
![]() |
|
Top Research & Recommendations Posts
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)







